![ACLA: Low Reimbursement Jeopardizes Monkeypox Lab Testing Effort](https://www.g2intelligence.com/wp-content/uploads/2022/10/Oct19-2022.News_.MonkeypoxTestReimbursement-iStock-1800x1250-1-1080x675.jpg)
ACLA: Low Reimbursement Jeopardizes Monkeypox Lab Testing Effort
Medicare Administrative Contractors are shortchanging labs on monkeypox test reimbursement, association says.
Medicare Administrative Contractors are shortchanging labs on monkeypox test reimbursement, association says.
Abbott has once more gotten the jump by becoming the first company to get EUA clearance for a commercial monkeypox RT-PCR test kit.
Abbott’s Alinity m MPXV assay for detecting DNA from the monkeypox virus received FDA EUA on Oct. 7.
Despite lessons learned from COVID-19 testing, HHS and FDA plan for monkeypox testing remains flawed.
ACLA and public health experts warn that current reimbursement rates will hamper US efforts to contain monkeypox spread.